BioXcel Therapeutics, Inc.
BTAI
$4.98
-$0.25-4.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.44M | 31.01M | 29.85M | 40.39M | 56.27M |
| Total Receivables | 17.00K | -- | 131.00K | 3.00K | 812.00K |
| Inventory | 506.00K | 642.00K | 679.00K | 1.53M | 2.68M |
| Prepaid Expenses | 5.15M | 4.74M | 5.29M | 4.48M | 2.78M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.14M | 1.39M | 1.44M | 1.40M | 1.64M |
| Total Current Assets | 25.24M | 37.78M | 37.39M | 47.79M | 64.18M |
|
|
|||||
| Total Current Assets | 25.24M | 37.78M | 37.39M | 47.79M | 64.18M |
| Net Property, Plant & Equipment | 546.00K | 702.00K | 857.00K | 1.01M | 1.17M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 87.00K | 87.00K | 87.00K | 87.00K |
| Total Assets | 25.79M | 38.57M | 38.34M | 48.89M | 65.44M |
|
|
|||||
| Total Accounts Payable | 16.69M | 15.45M | 15.99M | 14.89M | 13.26M |
| Total Accrued Expenses | 5.10M | 3.79M | 5.78M | 8.57M | 13.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.47M | 5.96M | 374.00K | 368.00K | 361.00K |
| Total Finance Division Other Current Liabilities | 108.00K | 345.00K | 91.00K | 1.73M | 177.00K |
| Total Other Current Liabilities | 108.00K | 345.00K | 91.00K | 1.73M | 177.00K |
| Total Current Liabilities | 33.38M | 25.55M | 22.23M | 25.56M | 27.29M |
|
|
|||||
| Total Current Liabilities | 33.38M | 25.55M | 22.23M | 25.56M | 27.29M |
| Long-Term Debt | 97.47M | 99.92M | 102.51M | 104.44M | 103.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 65.00K | 161.00K | 256.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.61M | 3.27M | 6.63M | 4.37M | 9.19M |
| Total Liabilities | 133.46M | 128.74M | 131.44M | 134.53M | 139.74M |
|
|
|||||
| Common Stock & APIC | 568.97M | 567.28M | 557.10M | 553.71M | 551.39M |
| Retained Earnings | -676.64M | -657.45M | -650.20M | -639.34M | -625.69M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -107.67M | -90.17M | -93.10M | -85.63M | -74.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -107.67M | -90.17M | -93.10M | -85.63M | -74.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -107.67M | -90.17M | -93.10M | -85.63M | -74.30M |
|
|
|||||